Science

Xu Lin, Vice head of the Publicity Department of Communist Party shows a copy of the white paper on fighting COVID-19 China in action during a press conference at the State Council Information Office in Beijing, Sunday, June 7, 2020. Senior Chinese health officials defended their country's response to the new coronavirus pandemic, saying they provided information in a timely and transparent manner. (AP Photo/Andy Wong)
1010 WINS Newsroom
June 07, 2020 - 5:39 am
BEIJING (AP) — Senior Chinese officials released a lengthy report Sunday on the nation's response to the coronavirus pandemic, defending their government's actions and saying that China had provided information in a timely and transparent manner. China “wasted no time" in sharing information such...
Read More
FILE - In this Friday, Oct. 25, 2019, file photo, Facebook CEO Mark Zuckerberg speaks about "News Tab" at the Paley Center, in New York. Dozens of scientists doing research funded by Zuckerberg say Facebook should not be letting President Donald Trump use the platform to spread "misinformation and incendiary statements.” Sixty professors at leading U.S. research institutions signed a letter Saturday, June 6, 2020, asking Zuckerberg to be less tolerant of harmful language. (AP Photo/Mark Lennihan, File)
1010 WINS Newsroom
June 06, 2020 - 9:36 pm
BOSTON (AP) — Dozens of scientists doing research funded by Mark Zuckerberg say Facebook should not be letting President Donald Trump use the social media platform to “spread both misinformation and incendiary statements.” The researchers, including 60 professors at leading U.S. research...
Read More
FILE - This Monday, April 6, 2020 file photo shows an arrangement of hydroxychloroquine pills in Las Vegas. On Friday, June 5, 2020, leaders of a large study in the United Kingdom that is rigorously testing the malaria drug hydroxychloroquine and other medicines for hospitalized COVID-19 patients say they will stop putting people on the drug because it’s clear it isn’t helping. (AP Photo/John Locher)
1010 WINS Newsroom
June 05, 2020 - 12:34 pm
Leaders of a large study in the United Kingdom that is rigorously testing the malaria drug hydroxychloroquine and other medicines for hospitalized COVID-19 patients say they will stop putting people on the drug because it’s clear it isn’t helping. Results released Friday from 1,542 patients showed...
Read More
FILE - This April 7, 2020 file photo shows a bottle of hydroxychloroquine tablets in Texas City, Texas. Several authors of a large study that raised safety concerns about malaria drugs for coronavirus patients have retracted the report, saying independent reviewers were not able to verify information that’s been widely questioned by other scientists. A retraction in the journal Lancet on Thursday, June 4, 2020 involved a May 22 report on hydroxychloroquine and chloroquine, drugs long used for preventing or treating malaria but whose safety and effectiveness for COVID-19 are unknown. (AP Photo/David J. Phillip, File)
1010 WINS Newsroom
June 04, 2020 - 5:20 pm
Several authors of a large study that raised safety concerns about malaria drugs for coronavirus patients have retracted the report, saying independent reviewers were not able to verify information that’s been widely questioned by other scientists. Thursday’s retraction in the journal Lancet...
Read More
In this Monday, June 1, 2020 photo, people walk past a terrace bar with local customers in Barcelona downtown. Spain's strict lockdown that it is now scaling back managed to eventually control a COVID-19 outbreak that has claimed at least 27,000 lives. (AP Photo/Emilio Morenatti)
1010 WINS Newsroom
June 04, 2020 - 2:55 pm
MADRID (AP) — A second round of random testing in Spain for antibodies to the new coronavirus indicates that a third of those infected do not develop symptoms, Spanish health authorities said Thursday. “It is a wake-up call for public health: it is not possible to control (an outbreak) by just...
Read More
FILE - This Monday, April 6, 2020 file photo shows an arrangement of hydroxychloroquine pills in Las Vegas. On Tuesday, June 2, 2020, concerns are mounting about studies in two influential medical journals on drugs used in people with coronavirus, including one that led multiple countries to stop testing a malaria pill. (AP Photo/John Locher,File)
1010 WINS Newsroom
June 02, 2020 - 4:06 pm
Concerns are mounting about studies in two influential medical journals on drugs used in people with coronavirus, including one that led multiple countries to stop testing a malaria pill. The New England Journal of Medicine issued an “ expression of concern ” Tuesday on a study it published May 1...
Read More
Matt Hancock Britain's Secretary of State for Health is driven through the entrance to Parliament in London, Tuesday, June 2, 2020. The British government has decided to scrap a remote-voting system used during the coronavirus pandemic, and has summoned lawmakers back to parliament on Tuesday, but many aren't happy with the arrangements. (AP Photo/Frank Augstein)
1010 WINS Newsroom
June 02, 2020 - 2:03 pm
LONDON (AP) — People from ethnic minorities have died from COVID-19 in larger relative numbers in England than their white compatriots, according to a study published by health authorities Tuesday. The Public Health England report hinted at reasons for the discrepancy but didn't offer any...
Read More
FILE - This is an April 30, 2020, file photo showing Gilead Sciences headquarters in Foster City, Calif. A California biotech company says its experimental drug remdesivir improved symptoms when given for five days to moderately ill, hospitalized patients with COVID-19. Gilead Sciences gave few details on Monday, June 1, 2020, but said full results would soon be published in a medical journal. (AP Photo/Ben Margot, File)
1010 WINS Newsroom
June 01, 2020 - 11:53 am
A California biotech company says its experimental drug remdesivir improved symptoms when given for five days to moderately ill, hospitalized patients with COVID-19. Gilead Sciences gave few details on Monday but said full results would soon be published in a medical journal. Remdesivir is the only...
Read More
This image made available by the U.S. Food and Drug Administration on Thursday, May 28, 2020 shows a label for the drug metformin. U.S. health regulators are telling five drugmakers to recall versions of the widely used diabetes medication after testing revealed elevated levels of a contaminant linked to cancer in several lots. (FDA via AP)
1010 WINS Newsroom
May 29, 2020 - 3:00 pm
WASHINGTON (AP) — U.S. health regulators are telling five drugmakers to recall their versions of a widely used diabetes medication after laboratory tests found elevated levels of a contaminant linked to cancer. The Food and Drug Administration said late Thursday that several batches of the drug...
Read More
This microscope image made available by the National Cancer Institute Center for Cancer Research in 2015 shows human colon cancer cells with the nuclei stained red. On Friday, May 29, 2020, doctors are reporting success with newer drugs that control certain types of cancer better, reduce the risk it will come back and make treatment simpler and easier to bear. (NCI Center for Cancer Research via AP)
1010 WINS Newsroom
May 29, 2020 - 8:32 am
Doctors are reporting success with newer drugs that control certain types of cancer better, reduce the risk it will come back and make treatment simpler and easier to bear. Gentler drugs would be a relief to patients like Jenn Carroll, a 57-year-old human resources director from New Hartford,...
Read More

Pages